Yes, perhaps.Discussions have continued with a number of POTENTIAL INVESTORS and with the Company’s banking syndicate.Seems like a cryptic terms for a suitor.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%